SUPARTZ (Artzal)  is a solution made of highly purified sodium hyaluronate (hyaluronan). Hyaluronan is a natural chemical found in the body and is found in particularly high amounts in joint tissues and in the fluid (synovial fluid) that fills the joints. The body's own hyaluronan acts like a lubricant and shock absorber in synovial fluid of a healthy joint. Osteoarthritis reduces your synovial fluid's ability to protect and lubricate your joint.

SUPARTZ (Artzal)  Joint Fluid Therapy was the first hyaluronan treatment approved for the relief of osteoarthritis (OA) pain in 1987 in Japan. Since 1987, over 143 million injections of SUPARTZ (Artzal) Joint Fluid Therapy have been sold worldwide.

SUPARTZ (Artzal)  Joint Fluid Therapy is the most prescribed Joint Fluid Therapy in the world.

In clinical studies, SUPARTZ (Artzal) Joint Fluid Therapy has been shown to be effective in the treatment of knee OA pain.

In a 1996 study, SUPARTZ (Artzal) Joint Fluid Therapy produced clinically significant results which were described by the author as the "equivalent of a doubled maximum walking distance combined with a complete loss of night pain."

SUPARTZ (Artzal)  Joint Fluid Therapy has a greater amount of active ingredient per treatment series than other Joint Fluid Therapies